KPC PHARMACEUTICALS, INC
5Patents
5Active
5Granted
46Portfolio score
Filing activity: Apr 12, 2013 → Dec 29, 2020
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9623111B2 | Pegylated artesunate derivative, pharmaceutical composition and use thereof | Emerging Cross-Sectional Technologies | 1 | Active |
| US12391653B2 | Salt form and crystal form of mutant IDH1 inhibitor and preparation method therefor | Chemistry; Metallurgy | 0 | Active |
| US11744841B2 | Use of trezastilbenoside in manufacture of product for treating and/or preventing disease of respiratory system | Human Necessities | 0 | Active |
| US10307453B2 | Method for extracting stilbene compounds | Human Necessities | 0 | Active |
| US11407717B2 | Benzimidazole derivatives and use thereof as IDH1 inhibitors | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.